Trial Outcomes & Findings for Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses (NCT NCT01244516)

NCT ID: NCT01244516

Last Updated: 2018-06-19

Results Overview

Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

540 participants

Primary outcome timeframe

after 2 weeks of contact lens wear

Results posted on

2018-06-19

Participant Flow

There were thirty-five sites recruited in the US. There were 540 subjects recruited with 520 enrolled and randomized. The study was a 2-week, randomized, single-masked (subjects), parallel arm, bilateral dispensing study. The subject group was expected to be representative of a cross-section of the population within the US contact lens market.

There were 20 subjects who did not meet the inclusion or did meet the exclusion criteria. There were 10 screen failures and 10 who wore spectacles to baseline visit invoking the exclusion criteria.

Participant milestones

Participant milestones
Measure
Galyfilcon A
Subjects that were randomized to receive the galyfilcon A lens with a base curve of 8.30 throughout the entire course of the study.
Lotrafilcon B
Subjects that were randomized to wear lotrafilcon B lens throughout the course of the study.
Comfilcon A
Subjects that were randomized to wear comfilcon A lens throughout the course of the study.
Period 1 (Baseline to 1-week Visit)
STARTED
170
177
173
Period 1 (Baseline to 1-week Visit)
COMPLETED
166
171
170
Period 1 (Baseline to 1-week Visit)
NOT COMPLETED
4
6
3
Period 2 (1-week to 2-week Visit)
STARTED
166
171
170
Period 2 (1-week to 2-week Visit)
COMPLETED
163
170
168
Period 2 (1-week to 2-week Visit)
NOT COMPLETED
3
1
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Galyfilcon A
Subjects that were randomized to receive the galyfilcon A lens with a base curve of 8.30 throughout the entire course of the study.
Lotrafilcon B
Subjects that were randomized to wear lotrafilcon B lens throughout the course of the study.
Comfilcon A
Subjects that were randomized to wear comfilcon A lens throughout the course of the study.
Period 1 (Baseline to 1-week Visit)
Protocol Violation
4
5
2
Period 1 (Baseline to 1-week Visit)
Poor Vision
0
1
0
Period 1 (Baseline to 1-week Visit)
Poor comfort
0
0
1
Period 2 (1-week to 2-week Visit)
Adverse Event
2
0
0
Period 2 (1-week to 2-week Visit)
Protocol Violation
1
0
1
Period 2 (1-week to 2-week Visit)
Lost to Follow-up
0
1
0
Period 2 (1-week to 2-week Visit)
Poor Comfort
0
0
1

Baseline Characteristics

Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Galyfilcon A
n=163 Participants
Subjects that were randomized to receive the galyfilcon A lens with a base curve of 8.30 throughout the entire course of the study.
Lotrafilcon B
n=170 Participants
Subjects that were randomized to wear lotrafilcon B lens throughout the course of the study.
Comfilcon A
n=168 Participants
Subjects that were randomized to wear comfilcon A lens throughout the course of the study.
Total
n=501 Participants
Total of all reporting groups
Age, Continuous
28.8 years
STANDARD_DEVIATION 5.9 • n=5 Participants
28.3 years
STANDARD_DEVIATION 5.6 • n=7 Participants
27.4 years
STANDARD_DEVIATION 5.7 • n=5 Participants
28.2 years
STANDARD_DEVIATION 5.7 • n=4 Participants
Sex: Female, Male
Female
108 Participants
n=5 Participants
118 Participants
n=7 Participants
115 Participants
n=5 Participants
341 Participants
n=4 Participants
Sex: Female, Male
Male
55 Participants
n=5 Participants
52 Participants
n=7 Participants
53 Participants
n=5 Participants
160 Participants
n=4 Participants
Region of Enrollment
United Kingdom
163 Participants
n=5 Participants
170 Participants
n=7 Participants
168 Participants
n=5 Participants
501 Participants
n=4 Participants

PRIMARY outcome

Timeframe: after 2 weeks of contact lens wear

Population: Analysis is on those subjects who completed the study (n=501).

Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.

Outcome measures

Outcome measures
Measure
Galyfilcon A
n=163 Participants
Subjects that were randomized to receive the galyfilcon A lens with a base curve of 8.30 throughout the entire course of the study.
Lotrafilcon B
n=170 Participants
Subjects that were randomized to wear lotrafilcon B lens throughout the course of the study.
Comfilcon A
n=168 Participants
Subjects that were randomized to wear comfilcon A lens throughout the course of the study.
Overall Subjective Comfort
51.7 CLUE score
Standard Error 2.1
51.3 CLUE score
Standard Error 2.0
51.3 CLUE score
Standard Error 2.0

PRIMARY outcome

Timeframe: after 2 weeks of contact lens wear

Population: Analysis is on those subjects who completed the study (n=501).

Investigator evaluated corneal staining. Percent of eyes with corneal staining presence or absence is evaluated.

Outcome measures

Outcome measures
Measure
Galyfilcon A
n=326 Eyes
Subjects that were randomized to receive the galyfilcon A lens with a base curve of 8.30 throughout the entire course of the study.
Lotrafilcon B
n=340 Eyes
Subjects that were randomized to wear lotrafilcon B lens throughout the course of the study.
Comfilcon A
n=336 Eyes
Subjects that were randomized to wear comfilcon A lens throughout the course of the study.
Corneal Staining
No corneal staining
78.5 percentage of eyes
67.1 percentage of eyes
66.1 percentage of eyes
Corneal Staining
With corneal staining
21.5 percentage of eyes
32.9 percentage of eyes
33.9 percentage of eyes

SECONDARY outcome

Timeframe: after 2 weeks of contact lens wear

Population: Analysis is on those subjects who completed the study (n=331) and where assigned to these two arms. Analysis is restricted to these two arms for this outcome as specified per protocol.

Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0 to 120. Only galyficlon A and comfilcon A were evaluated.

Outcome measures

Outcome measures
Measure
Galyfilcon A
n=163 Participants
Subjects that were randomized to receive the galyfilcon A lens with a base curve of 8.30 throughout the entire course of the study.
Lotrafilcon B
n=168 Participants
Subjects that were randomized to wear lotrafilcon B lens throughout the course of the study.
Comfilcon A
Subjects that were randomized to wear comfilcon A lens throughout the course of the study.
Overall Subjective Lens Handling
64.3 CLUE score
Standard Error 1.6
59.8 CLUE score
Standard Error 1.6

Adverse Events

Galyfilcon A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Lotrafilcon B

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Comfilcon A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Kathy Osborn, OD

Johnson & Johnson Vision Care

Phone: 1-904-443-1032

Results disclosure agreements

  • Principal investigator is a sponsor employee Publication required agreement and written authorization from the Sponsor.
  • Publication restrictions are in place

Restriction type: OTHER